01
Continuous monitoring
Intermittent tests can miss rapid biomarker changes. We develop stable aptamer-based sensors to track drugs and biomarkers continuously, supporting timely, personalised treatment.
Creating functionalising sensing platforms for rapid, continuous, and real-time biomarker monitoring.

Intermittent tests can miss rapid biomarker changes. We develop stable aptamer-based sensors to track drugs and biomarkers continuously, supporting timely, personalised treatment.
Early detection requires reliable measurement of scarce targets. We leverage functional probes, microfluidics, and CRISPR assays for molecular analysis.
Laboratory tests offer limited insight into daily health changes. We integrate electrochemical sensors into wearable platforms to enable accessible monitoring beyond the lab.